Telisotuzumab (powder) (Synonyms:特立妥珠单抗)
目录号 : KM38268 CAS No. : 1781223-80-0
Telisotuzumab (ABT-700) (powder) 是一种二价人源化 IgG1 抗 c-Met 单克隆抗体。Telisotuzumab (powder) 可结合细胞内的 c-Met,并阻断其由 HGF 或细胞表面高密度 c-Met 诱导的二聚化和活化,且不依赖于配体。Telisotuzumab (powder) 可诱导细胞凋亡 (apoptosis)。Telisotuzumab (powder) 可用于研究携带 MET 扩增的癌症,例如胃癌和肺癌。
规格 价格 是否有货 数量
1mg 询价 In-stock
5mg 询价 In-stock
10mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Telisotuzumab (ABT-700) (powder) is a bivalent humanized IgG1 anti-c-Met monoclonal antibody. Telisotuzumab (powder) binds cellular c-Met and disrupts its productive dimerization and activation induced by HGF or by the high density of c-Met on the cell surface independent of ligand. Telisotuzumab (powder) induces apoptosis. Telisotuzumab (powder) can be used for the study of cancers harboring amplified MET, such as gastric and lung cancers.
分子量
146.1 kDa
CAS号
1781223-80-0
中文名称
Telisotuzumab
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2